CJC-1295 (no dac) + Ipamorelin

Description

CJC-1295 5mg + Ipamorelin 5mg is a powerful peptide pairing formulated for advanced studies into endocrine regulation and growth hormone (GH) pathways. Together, these peptides target distinct mechanisms to produce a synergistic effect on GH secretion, making them valuable tools for metabolic and regenerative research. Peptide Components CJC-1295 (5mg): A synthetic analogue of growth hormone–releasing hormone (GHRH), engineered for extended half-life and stability. It stimulates the anterior pituitary to release growth hormone in a more sustained manner compared to native GHRH. Ipamorelin (5mg): A selective growth hormone–releasing peptide (GHRP) that mimics the action of ghrelin on the ghrelin receptor, promoting GH release without significant effects on appetite or cortisol. Known for its clean, targeted activity profile. Research Significance When combined, CJC-1295 and Ipamorelin work through complementary mechanisms (GHRH receptor + ghrelin receptor), which has been studied for: Enhanced growth hormone secretion models Metabolism and body composition research Cellular recovery and repair studies Investigations into anti-aging and regenerative pathways Specifications Form: Lyophilized peptide powder Content: CJC-1295 5mg + Ipamorelin 5mg per vial Storage: Store at -20°C; once reconstituted, use promptly under sterile lab conditions